Since COVID-19 engulfed the world two years ago, “unprecedented” has become something of a buzzword. Yet while the coronavirus has posed unique challenges at a time of deep global interconnectedness, pandemics are nothing new.
The COVID-19 pandemic is not even the only one we are experiencing. In much of the developing world, cholera outbreaks are proliferating.
Whereas SARS-CoV-2 is “novel,” cholera — a water-borne diarrheal disease caused by the bacteria Vibrio cholerae — is ancient, as is its history of widespread devastation. The current cholera pandemic is the world’s seventh since the early 19th century.
Despite their apparent differences, COVID-19 and cholera have much in common. Both are at least partly controllable by vaccination, and both spread most easily in crowded, unsanitary environments. Ensuring adequate shelter and strengthening water, sanitation and hygiene practices and infrastructure are therefore vital to limit transmission.
These commonalities explain why measures to limit COVID-19, such as decreased travel and increased vigilance regarding personal hygiene, brought about a decline in cholera cases.
However, as the world’s governments roll back pandemic restrictions, cholera is returning with a vengeance. At the end of last year, there were 16 active cholera outbreaks worldwide.
Yet the response to COVID-19 still holds valuable lessons for bolstering the fight against cholera, beginning with the importance of research to combat disease outbreaks.
The emergence of SARS-CoV-2 triggered a massive and largely coordinated global research push that enabled evidence-based decisionmaking at all levels of prevention and control. Initiatives such as the WHO’s Global Research Roadmap for COVID-19 helped guide this effort, ensuring that resources were channeled to the areas where knowledge and innovation were most needed.
Research is no less important in the fight against cholera. That is why, last year, the Global Task Force on Cholera Control (GTFCC) launched the Cholera Roadmap Research Agenda.
Representing the collective vision of 177 global cholera experts and other stakeholders, the agenda identifies the highest-priority research questions. Getting the answers is essential to achieving the goals set out in the GTFCC’s Ending Cholera by 2030 global roadmap.
Many of the questions could just as easily be found in a COVID-19 research agenda.
For example, what is the fastest, most cost-effective way to deliver a limited supply of vaccines? How can the uptake and sustainability of response measures be enhanced to prevent the disease from reaching epidemic or pandemic-level proportions? How does one engage meaningfully with at-risk communities in designing and implementing interventions? Which disease surveillance systems are the most effective, and when and where should they be deployed?
The questions might be the same, but the efforts devoted to answering them has been very different. With COVID-19, strong political will and massive investment enabled researchers to produce answers quickly. Although cholera has been around much longer, solutions remain elusive.
A key reason is that, whereas COVID-19 ravaged developed and developing countries alike, cholera was eradicated from the Global North more than 150 years ago. It is much harder to mobilize resources to tackle a disease affecting the world’s poorest and most marginalized people.
With just a fraction of the commitment underpinning the fight against COVID-19, lifesaving progress could be made in cholera research. Epidemiological surveillance would enable the mapping of transmission patterns. New and innovative diagnostic tests could increase the speed, efficiency and quality of detecting and confirming cases. New or improved vaccines would also bolster the connection between emergency response and long-term control and prevention.
Optimizing the timing and dosage of vaccines is essential, as is learning how to engage communities to ensure that the needs of marginalized populations are met. Transforming treatment for vulnerable communities requires studying the effect of antibiotics on cholera transmission and understanding what enables — and blocks — integration of cholera treatment into case management by community health workers.
Equipped with this knowledge, countries and health partners would be better positioned to choose the most effective tools and approaches as they pursue their national cholera plans. This, in turn, would make it easier to attract additional funding, which would drive further progress.
The world has learned so much during the COVID-19 pandemic. People have listened to their public-health officials and taken steps to limit the spread of the virus: wearing face masks, practicing social distancing, quarantining, getting vaccinated and washing their hands more regularly.
This increased awareness and momentum must be leveraged to make further public-health gains worldwide.
That means taking aim at other, much older scourges. The world has the tools needed to defeat cholera, but research is required to identify how, when and where to use them. Only then can the planet’s most vulnerable populations be protected from this all-too-precedented disease.
Firdausi Qadri is a senior scientist and head of the Mucosal Immunology and Vaccinology Unit at the International Centre for Diarrhoeal Disease Research in Dhaka. Md. Taufiqul Islam is deputy project coordinator in the Mucosal Immunology and Vaccinology Unit at the International Centre for Diarrhoeal Disease Research in Dhaka.
Copyright: Project Syndicate
The EU’s biggest banks have spent years quietly creating a new way to pay that could finally allow customers to ditch their Visa Inc and Mastercard Inc cards — the latest sign that the region is looking to dislodge two of the most valuable financial firms on the planet. Wero, as the project is known, is now rolling out across much of western Europe. Backed by 16 major banks and payment processors including BNP Paribas SA, Deutsche Bank AG and Worldline SA, the platform would eventually allow a German customer to instantly settle up with, say, a hotel in France
On August 6, Ukraine crossed its northeastern border and invaded the Russian region of Kursk. After spending more than two years seeking to oust Russian forces from its own territory, Kiev turned the tables on Moscow. Vladimir Putin seemed thrown off guard. In a televised meeting about the incursion, Putin came across as patently not in control of events. The reasons for the Ukrainian offensive remain unclear. It could be an attempt to wear away at the morale of both Russia’s military and its populace, and to boost morale in Ukraine; to undermine popular and elite confidence in Putin’s rule; to
A traffic accident in Taichung — a city bus on Sept. 22 hit two Tunghai University students on a pedestrian crossing, killing one and injuring the other — has once again brought up the issue of Taiwan being a “living hell for pedestrians” and large vehicle safety to public attention. A deadly traffic accident in Taichung on Dec. 27, 2022, when a city bus hit a foreign national, his Taiwanese wife and their one-year-old son in a stroller on a pedestrian crossing, killing the wife and son, had shocked the public, leading to discussions and traffic law amendments. However, just after the
With escalating US-China competition and mutual distrust, the trend of supply chain “friend shoring” in the wake of the COVID-19 pandemic and the fragmentation of the world into rival geopolitical blocs, many analysts and policymakers worry the world is retreating into a new cold war — a world of trade bifurcation, protectionism and deglobalization. The world is in a new cold war, said Robin Niblett, former director of the London-based think tank Chatham House. Niblett said he sees the US and China slowly reaching a modus vivendi, but it might take time. The two great powers appear to be “reversing carefully
RSS